Report Search Results	As of 10-Feb-2010
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 37) Release Date  Contributor Author Title Pages Price StarMine Author Rating More Info EPS Accuracy * Portfolio Return ** 9-Feb-10 EconomicInvestor N/A "The Economy Matters" Report for NKTR: the economy's impact on NKTR's price and risk, featuring the powerful EconomicInvestor Star Rating 6 $15     View Abstract 8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Plunkett's Health Care Technologies Overview 2010 (Summary) 80 $199     View Abstract 8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 569 $299     View Abstract 8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) 71 $199     View Abstract 8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Health Care Industry Market Research and Competitive Analysis 2010 730 $299     View Abstract 8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Health Care Industry Trends, Statistics & Analysis 2010 (Summary) 98 $199     View Abstract 7-Feb-10 Wright Reports N/A Wright Industry Averages: Health, Medicine and Pharmaceuticals (North America) 100 $169     View Abstract 7-Feb-10 Wright Reports N/A Wright Industry Averages: Health, Medicine and Pharmaceuticals (United States) 98 $169     View Abstract 5-Feb-10 Ford Investor Services, Inc. N/A Value Graph: NEKTAR THERAPEUT -- NKTR 1 $4     View Abstract 5-Feb-10 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of NEKTAR THERAPEUTICS including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 11 $20     View Abstract Next 20

Brokerage Reports (Showing 1 to 2 of 2) Release Date  Contributor Author Title Pages Price StarMine Author Rating More Info EPS Accuracy * Portfolio Return ** 19-Jan-10 Brean Murray & Co., Inc. Jonathan M. Aschoff PhD NKTR: Recent Data Reduces Risk in Pegylating Small Molecule Drugs – Raising Target Price 4 $10     View Abstract 12-Jan-10 Brean Murray & Co., Inc. Jonathan M. Aschoff PhD NKTR: Nektar Therapeutics (Nektar Announces Impressive Preliminary Results from NKTR-102 Phase 2 Trial in Platinum-Resistant Ovarian Cancer Patients 4 $10     View Abstract

Independent Reports (Showing 1 to 10 of 35) Release Date  Contributor Author Title Pages Price More Info 9-Feb-10 EconomicInvestor N/A "The Economy Matters" Report for NKTR: the economy's impact on NKTR's price and risk, featuring the powerful EconomicInvestor Star Rating 6 $15 View Abstract 8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Plunkett's Health Care Technologies Overview 2010 (Summary) 80 $199 View Abstract 8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 569 $299 View Abstract 8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) 71 $199 View Abstract 8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Health Care Industry Market Research and Competitive Analysis 2010 730 $299 View Abstract 8-Feb-10 Plunkett Research, Ltd. Jack W. Plunkett Health Care Industry Trends, Statistics & Analysis 2010 (Summary) 98 $199 View Abstract 7-Feb-10 Wright Reports N/A Wright Industry Averages: Health, Medicine and Pharmaceuticals (North America) 100 $169 View Abstract 7-Feb-10 Wright Reports N/A Wright Industry Averages: Health, Medicine and Pharmaceuticals (United States) 98 $169 View Abstract 5-Feb-10 Ford Investor Services, Inc. N/A Value Graph: NEKTAR THERAPEUT -- NKTR 1 $4 View Abstract 5-Feb-10 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of NEKTAR THERAPEUTICS including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 11 $20 View Abstract Next 20